Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 ...
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 ...
NVIDIA’S revenue forecast on Wednesday (Nov 20) disappointed Wall Street, raising questions over whether the artificial-intelligence (AI) boom is waning. ...
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
Arta Finance provides a gateway to private market investments, enabling access to investment tools and financial solutions THE strategic investment ...
© 2024 forbes50under50 - All Rights Reserved.
© 2024 forbes50under50 - All Rights Reserved.